Hormone Research in Paediatrics
Original Paper
Effects of Phytoestrogen Extracts Isolated from Rye, Green and Yellow Pea Seeds on Hormone Production and Proliferation of Trophoblast Tumor Cells Jeg3Matscheski A.a · Richter D.-U.c · Hartmann A.-M.a · Effmert U.a · Jeschke U.b · Kupka M.S.b · Abarzua S.a · Briese V.c · Ruth W.d · Kragl U.d · Piechulla B.aaDepartment of Biological Sciences, University of Rostock, Rostock, bFirst Department of Obstetrics and Gynaecology, Ludwig-Maximilians-University of Munich, Munich, Departments of cObstetrics and Gynaecology and dTechnical Chemistry, University of Rostock, Rostock, Germany
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: May 13, 2005
Accepted: February 20, 2006
Published online: June 09, 2006
Issue release date: June 2006
Number of Print Pages: 13
Number of Figures: 11
Number of Tables: 0
ISSN: 1663-2818 (Print)
eISSN: 1663-2826 (Online)
For additional information: https://www.karger.com/HRP
Abstract
Background: Phytoestrogens are a diverse group of non-steroidal plant compounds. Because they have chemical structures similar to estrogens they are able to bind on estrogen receptors in humans. Objectives: In this study, we tested the effects of crude phytoestrogen extracts from rye (Secale cereale), green pea (Pisum sativum) and yellow pea seeds (Pisum sativum cv.) on cell proliferation and the production of progesterone in trophoblast tumor cells of the cell line Jeg3. Methods: Isoflavone extracts from green and yellow pea seeds and lignan extracts from rye seeds were obtained, using different extraction methods. Isolated extracts were incubated in different concentrations with trophoblast tumor cells. Untreated cells were used as controls. At designated times, aliquots were removed and tested for estradiol and progesterone production. In addition, we tested the effects of the phytoestrogen extracts on cell proliferation. Results: Cell proliferation is significantly inhibited by potential phytoestrogens isolated from rye, green and yellow pea seeds in trophoblast tumor cells of the cell line Jeg3. We found a correlation between the effects of proliferation and production of estradiol in isoflavone extracts from green and yellow pea seeds in Jeg3 cells. In addition, higher concentrations of isoflavones isolated from green pea seeds and lignans from rye showed also a inhibition of progesterone production whereas higher concentrations of rye lignans elevated estradiol production in Jeg3 cells. Conclusion: A useful indicator test system for potential phytoestrogens could be established. Based on the obtained results it is proposed that green and yellow pea seeds contain measurable concentrations of isoflavones and rye seeds contain lignans which can be isolated and used for special human diet programs.
© 2006 S. Karger AG, Basel
Related Articles:
References
-
Setchell KD: Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998;68:1333S–1346S.
- Price KR, Fenwick GR: Naturally occurring oestrogens in foods – a review. Food Addit Contam 1985;2:73–106.
- Manas ES, Xu ZB, Unwalla RJ, Somers WS: Understanding the selectivity of genistein for human estrogen receptor-beta using X-ray crystallography and computational methods. Structure (Camb) 2004;12:2197–2207.
- Messina MJ, Persky V, Setchell KD, Barnes S: Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994;21:113–131.
- Park D, Huang T, Frishman WH: Phytoestrogens as cardioprotective agents. Cardiol Rev 2005;13:13–17.
- Begum AN, Nicolle C, Mila I, Lapierre C, Nagano K, Fukushima K, Heinonen SM, Adlercreutz H, Remesy C, Scalbert A: Dietary lignins are precursors of mammalian lignans in rats. J Nutr 2004;134:120–127.
- Adlercreutz H: Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 1995;7(suppl):103–112.
- Fournier DB, Erdman JW Jr, Gordon GB: Soy, its components, and cancer prevention: a review of the in vitro, animal, and human data. Cancer Epidemiol Biomarkers Prev 1998;7:1055–1065.
- Wei H, Wei L, Frenkel K, Bowen R, Barnes S: Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 1993;20:1–12.
- Glazier MG, Bowman MA: A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med 2001;161:1161–1172.
- Akiyama T, Ogawara H: Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol 1991;201:362–370.
- Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592–5595.
- Su SJ, Yeh TM, Chuang WJ, Ho CL, Chang KL, Cheng HL, Liu HS, Hsu PY, Chow NH: The novel targets for anti-angiogenesis of genistein on human cancer cells. Biochem Pharmacol 2005;69:307–318.
- Kaplanski O, Shemesh M, Berman A: Effects of phyto-oestrogens on progesterone synthesis by isolated bovine granulosa cells. J Endocrinol 1981;89:343–348.
- Whitehead SA, Cross JE, Burden C, Lacey M: Acute and chronic effects of genistein, tyrphostin and lavendustin A on steroid synthesis in luteinized human granulosa cells. Hum Reprod 2002;17:589–594.
- Basly JP, Lavier MC: Dietary phytoestrogens: potential selective estrogen enzyme modulators? Planta Med 2005;71:287–294.
- Chen S, Zhang F, Sherman MA, Kijima I, Cho M, Yuan YC, Toma Y, Osawa Y, Zhou D, Eng ET: Structure-function studies of aromatase and its inhibitors: a progress report. J Steroid Biochem Mol Biol 2003;86:231–237.
- Morrissey C, Watson RW: Phytoestrogens and prostate cancer. Curr Drug Targets 2003;4:231–241.
- Papiez M, Gancarczyk M, Bilinska B: The compounds from the hollyhock extract (Althaea rosea Cav. var. nigra) affect the aromatization in rat testicular cells in vivo and in vitro. Folia Histochem Cytobiol 2002;40:353–359.
- Almstrup K, Fernandez MF, Petersen JH, Olea N, Skakkebaek NE, Leffers H: Dual effects of phytoestrogens result in u-shaped dose-response curves. Environ Health Perspect 2002;110:743–748.
- Eng ET, Williams D, Mandava U, Kirma N, Tekmal RR, Chen S: Suppression of aromatase (estrogen synthetase) by red wine phytochemicals. Breast Cancer Res Treat 2001;67:133–146.
- Zhao J, Mak P, Tchoudakova A, Callard G, Chen S: Different catalytic properties and inhibitor responses of the goldfish brain and ovary aromatase isozymes. Gen Comp Endocrinol 2001;123:180–191.
- Kirk CJ, Harris RM, Wood DM, Waring RH, Hughes PJ: Do dietary phytoestrogens influence susceptibility to hormone-dependent cancer by disrupting the metabolism of endogenous oestrogens? Biochem Soc Trans 2001;29:209–216.
- Krazeisen A, Breitling R, Moller G, Adamski J: Phytoestrogens inhibit human 17beta-hydroxysteroid dehydrogenase type 5. Mol Cell Endocrinol 2001;171:151–162.
-
Chen S: Aromatase and breast cancer. Front Biosci 1998;3:d922–d933.
- Kao YC, Zhou C, Sherman M, Laughton CA, Chen S: Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study. Environ Health Perspect 1998;106:85–92.
- Adlercreutz H, Bannwart C, Wahala K, Makela T, Brunow G, Hase T, Arosemena PJ, Kellis JT Jr, Vickery LE: Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 1993;44:147–153.
- Plessow D, Waldschlager J, Richter DU, Jeschke U, Bruer G, Briese V, Friese K: Effects of phytoestrogens on the trophoblast tumour cell lines BeWo and Jeg3. Anticancer Res 2003;23:1081–1086.
- Waldschlager J, Bergemann C, Ruth W, Effmert U, Jeschke U, Richter DU, Kragl U, Piechulla B, Briese V: Flax-seed extracts with phytoestrogenic effects on a hormone receptor-positive tumour cell line. Anticancer Res 2005;25:1817–1822.
- Mylonas I, Jeschke U, Makovitzky J, Winkler L, Richter DU, Friese K, Briese V: Immunohistochemical expression of steroid receptors and glycodelin A in isolated proliferative human endometrial glandular cells after stimulation with tamoxifen and phytoestrogens (genistein and daidzein). Anticancer Res 2003;23:1119–1125.
-
Franz G KH: Allgemeine Nachweismethoden für Flavonoide in Drogen; in Franz G KH (ed): Drogen und Naturstoffe. Grundlagen und Praxis der chemischen Analyse.Berlin, Heidelberg, Springer Verlag, 1992, p 129.
-
Matscheski A: Untersuchungen zur Wirkung von Pflanzenextrakten aus Linum usitatissimum, Secale sereale und Pisum sativum auf die Zellproliferation und Progesteronproduktion von humanen Trophoblasttumorzellen; in Fachbereich Biowissenschaften, Biochemie. Rostock, Universität Rostock, 2003.
- Luyengi L SN, Fong HHS, Pezzuto JM, Kinghorn AD: A lignan and four terpenoids from Brucea javanica that induce differentiation with cultured HL-60 promeolytic leukemia cells. Phytochemistry 1996;43:409–412.
- Adlercreutz H, Mazur W: Phyto-oestrogens and Western diseases. Ann Med 1997;29:95–120.
- Anderson JJ, Garner SC: Phytoestrogens and bone. Baillieres Clin Endocrinol Metab 1998;12:543–557.
- An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC: Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 2001;276:17808–17814.
- Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252–4263.
- Barnes S: The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res Treat 1997;46:169–179.
-
Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A: Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 2002;132:552S–558S.
-
Lamartiniere CA, Zhang JX, Cotroneo MS: Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity. Am J Clin Nutr 1998;68:1400S–1405S.
- Allred CD, Allred KF, Ju YH, Goeppinger TS, Doerge DR, Helferich WG: Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 2004;25:1649–1657.
- Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG: Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res 2001;61:5045–5050.
- Sathyamoorthy N, Wang TT: Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur J Cancer 1997;33:2384–2389.
- Zaizen Y, Higuchi Y, Matsuo N, Shirabe K, Tokuda H, Takeshita M: Antitumor effects of soybean hypocotyls and soybeans on the mammary tumor induction by N-methyl-n-nitrosourea in F344 rats. Anticancer Res 2000;20:1439–1444.
- Ho CK, Chi CW, Yu KJ, Wang SY: Tamoxifen-mediated anti-cellular effect against a choriocarcinoma cell line. Int J Oncol 1998;12:1171–1176.
- Jiang SW, Lloyd RV, Jin L, Eberhardt NL: Estrogen receptor expression and growth-promoting function in human choriocarcinoma cells. DNA Cell Biol 1997;16:969–977.
Article / Publication Details
Received: May 13, 2005
Accepted: February 20, 2006
Published online: June 09, 2006
Issue release date: June 2006
Number of Print Pages: 13
Number of Figures: 11
Number of Tables: 0
ISSN: 1663-2818 (Print)
eISSN: 1663-2826 (Online)
For additional information: https://www.karger.com/HRP
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission